Increased left dorsolateral prefrontal cortex density following escitalopram intake during relearning: a randomized, placebo-controlled trial in healthy humans.

"The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: There are no conflicts of interest to declare regarding the present study. R. Lanzenberger received travel grants and/or conference speaker honoraria within the last 3 years from Bruker BioSpin MR and support from Siemens Healthcare regarding clinical research using PET/MR. He is a shareholder of the start-up company BM Health GmbH since 2019. S. Kasper has received grants/research support, consulting fees and/or honoraria within the last three years; grant/research support from Lundbeck; he has served as a consultant or on advisory boards Celegne, IQVIA, Janssen, Lundbeck, Mundipharma, Recordati, Takeda and Schwabe; and he has served on speakers bureaus for Angelini, Aspen Farmaceutica S.A., Janssen, Krka Pharma, Lundbeck, Medichem Pharmaceuticals Inc., Neuraxpharma, OM Pharma, Pierre Fabre, Sanofi, Servier, Schwabe, Sun Pharma. C. Kraus received travel grants from Roche and AOP Orphan Austria, speaker honoraria from Janssen. J. Unterholzner received travel grants from Medice Pharma GmbH. T. Vanicek received speaker honoraria from Janssen. M.B. Reed, R. Seiger, G.M. Godbersen, M. Klöbl, G. Gryglewski, Patricia Handschuh, C. Schmidt, T. Stimpfl, R. Rupprecht declare no conflicts of interest."

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded in whole, or in part, by the Austrian Science Fund (FWF) grant number KLI 516 to Rupert Lanzenberger, by the WWTF Vienna Science and Technology Fund grant number CS18-039, the Medical Imaging Cluster of the Medical University of Vienna, and by the grant ‘Interdisciplinary translational brain research cluster (ITHC) with highfield MR’ from the Federal Ministry of Science, Research and Economy (BMWFW), Austria. Manfred Klöbl and Murray Bruce Reed are recipients of a DOC fellowship of the Austrian Academy of Sciences at the Department of Psychiatry and Psychotherapy, Medical University of Vienna."

"The study was registered at clinicaltrials.gov with the identifier NCT02753738. The distributions of sex and age in between groups were tested using Fisher’s exact and that of age with a Kruskal–Wallis test. Registration:: ClinicalTrials.gov Identifier: NCT02753738; Trial Name: Enhancement of learning associated neural plasticity by Selective Serotonin Reuptake Inhibitors; URL: https://clinicaltrials.gov/ct2/show/NCT02753738."